NeurogesX, Inc. (NASDAQ:NGSX)
A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Momentum21
(96.66)
Submitted: 1/31/2012 10:55:48 AM :
Start Price:
$1.05
NGSX Score:
+46.97
These guys have some issues and the upcoming "catalyst" seems to favor a large haircut.
Recs
Recs
pennysplants
(99.45)
Submitted: 9/5/2007 5:55:00 PM :
Start Price:
$7.76
NGSX Score:
-88.19
NGSX has been on my watch list for ages, but was under the 100m market cap. So, I had to sit on my hands.
With phase 3 trial "results" announced yesterday, it's now "pickable". [And no, I don't hate myself in the mirror today. It's the 24 hour delay thing. I would have rather bought yesterday].
Pain patch. Chili peppers (don't laugh -- I'm a believer). Sufficient cash on hand to commercialize... or at least get er go'n.
AND, the head honcho made "the street.com" look like monkeys. I know that may not be hard to do ... but it's done so infrequently ... as to merit some notice.
Anyway, NGSX is for the speculative small cap portion of my portfolio. Hope it doesn't get bought out too soon.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 3 of 3